AI Science Tracker
EN

Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides.

Affiliation not stated in the reviewed material · 25 Nov 2022 · medicine

Discovery

Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Weakly supervised attention-MIL with ResNet50 features and autoencoder reduction distinguishes bladder cancer on slides and generates MIBC survival risk; internal TCGA and independent Renmin cohorts gave diagnostic external AUC .993 and prognostic external C-index .622. Retrospective with modest prognostic discrimination.

Technology: Weakly supervised attention-MIL with ResNet50 features and autoencoder reduction distinguishes bladder cancer on slides and generates MIBC survival risk; internal TCGA and independent Renmin cohorts gave diagnostic external AUC .9

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Weakly supervised attention-MIL with ResNet50 features and autoencoder reduction distinguishes bladder cancer on slides and generates MIBC survival risk; internal TCGA and independent Renmin cohorts gave diagnostic external AUC .993 and prognostic external C-index .622. Retrospective with modest prognostic discrimination.
Limitation / still unknown
Both diagnostic and prognostic evidence is retrospective; external prognostic discrimination was modest (C-index 0.622), and clinical benefit was not evaluated.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.mdpi.com/2072-6694/14/23/5807

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.